SS
Satya Suresh Venkata Attili
About Satya Suresh Venkata Attili
Data last updated:
Satya Suresh Venkata Attili is a Director at Clinsync Clinical Research Private Limited (since 2020), Director at Bio Fact Research Private Limited (since 2016) and Director at Cognitivecare India Labs Private Limited (since 2020), and holds 8 more current directorships. The companies operate in Pharma, Information Technology and Professional Services. The 3 current companies with reported revenue have a combined latest revenue of ₹19.45 Cr; the largest is Clinsync Clinical Research Private Limited at ₹15.75 Cr (FY 2025). Earlier, Satya Suresh Venkata Attili was a Director at M2m Pelvic Studio And Rehab Private Limited (2024) and Director at Gayatri Crl Private Limited (2023–2025) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Clinsync Clinical Research Private Limited U73200TG2011PTC073413 | Director | 30 Nov 2020 | 2011 | ₹15.75 Cr (FY 2025) | Active |
 Bio Fact Research Private Limited U73100AP2016PTC098553 | Director | 18 Mar 2016 | 2016 | ₹2.77 Cr (FY 2025) | Active |
 Cognitivecare India Labs Private Limited U74999TG2020PTC143875 | Director | 14 Sep 2020 | 2020 | ₹93 Lakh (FY 2023) | Active |
| Addsus Solutions And Services Llp ACV-0744 | Designated Partner | 06 Feb 2026 | 2026 | Active | |
| Arthavriddhi Ventures Llp ACK-6878 | Partner | 14 Feb 2025 | 2024 | Active | |
| Medhankura Private Limited U72100TS2024PTC189703 | Director | 28 Sep 2024 | 2024 | Active | |
| Digiring Hw Private Limited U62090TS2024PTC188491 | Director | 13 Aug 2024 | 2024 | Active | |
| Tips Engineering Private Limited U74999TG2020PTC138898 | Director | 31 Jan 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| M2m Pelvic Studio And Rehab Private Limited U86900TS2024PTC182921 | Director | 04 Mar 2024 | 2024 | Active | |
| Gayatri Crl Private Limited U74999TG2020PTC144157 | Director | 30 Mar 2023 | 2020 | ₹16.2 Lakh (FY 2021) | Active |
 Deepfacts Private Limited U33110TG2020PTC146874 | Director | 11 Oct 2021 | 2020 | ₹6.6 Lakh (FY 2024) | Active |
 Loyal Telesystems Private Limited U72200TG2014PTC093038 | Director | 30 Aug 2016 | 2014 | ₹17.7 Lakh (FY 2024) | Active |
| Bridge Gap Lifesciences Private Limited U85100TG2014PTC092530 | Director | 28 Jan 2014 | 2014 | ₹9.29 Cr (FY 2024) | Active |
 Davanagere Cancer Center Private Limited U85200TG2017PTC120907 | Director | 30 Nov 2017 | 2017 | ₹6,600 (FY 2021) | Active |
| Khammam Cancer Hospital Private Limited U85110TG2017PTC120545 | Director | 10 Nov 2017 | 2017 | Active | |
| Bridge Gap Hospitals Private Limited U85320TG2016PTC113538 | Director | 20 Dec 2016 | 2016 | ₹1.51 Cr (FY 2024) | Active |
| Cognitivecare India Labs Llp AAK-1443 | Designated Partner | 12 Jul 2018 | 2017 | Converted To Cmp And Dissolved | |
| Apointt Business Solutions Llp AAF-8823 | Designated Partner | 08 Mar 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satya Suresh Venkata Attili
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Suresh Venkata Attili
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Suresh Venkata Attili
Satya Suresh Venkata Attili currently holds 11 directorships: Clinsync Clinical Research Private Limited (Director, since 30 Nov 2020, revenue ₹15.75 Cr (FY 2025)); Bio Fact Research Private Limited (Director, since 18 Mar 2016, revenue ₹2.77 Cr (FY 2025)); Cognitivecare India Labs Private Limited (Director, since 14 Sep 2020, revenue ₹93 Lakh (FY 2023)); Addsus Solutions And Services Llp (Designated Partner, since 06 Feb 2026); Arthavriddhi Ventures Llp (Partner, since 14 Feb 2025); and 6 more.
Satya Suresh Venkata Attili was first appointed on 28 Jan 2014 as Director at Bridge Gap Lifesciences Private Limited. The most recent appointment on record is 06 Feb 2026 at Addsus Solutions And Services Llp.
The 3 current companies of Satya Suresh Venkata Attili that report revenue have a combined latest revenue of ₹19.45 Cr: Clinsync Clinical Research Private Limited ₹15.75 Cr (FY 2025); Bio Fact Research Private Limited ₹2.77 Cr (FY 2025); Cognitivecare India Labs Private Limited ₹93 Lakh (FY 2023).
Satya Suresh Venkata Attili held 10 earlier board appointments: M2m Pelvic Studio And Rehab Private Limited (Director, 04 Mar 2024 to 30 Sep 2024); Gayatri Crl Private Limited (Director, 30 Mar 2023 to 20 Jan 2025); Deepfacts Private Limited (Director, 11 Oct 2021 to 09 Mar 2023); Loyal Telesystems Private Limited (Director, 30 Aug 2016 to 17 Jul 2021); Bridge Gap Lifesciences Private Limited (Director, 28 Jan 2014 to 08 May 2019); and 5 more.
The current boards of Satya Suresh Venkata Attili's companies include Koteswara Prasad Sripathipanditaradhyula (Clinsync Clinical Research Private Limited), Sandhya Nandiraju (Clinsync Clinical Research Private Limited), Suresh Kumar Nandiraju (Clinsync Clinical Research Private Limited), Lakshmi Narayana Saripalli (Bio Fact Research Private Limited), Jagannadha Sarma Ganti (Cognitivecare India Labs Private Limited), Ajay P V S S Gopal (Addsus Solutions And Services Llp), among others.